Viewing Study NCT05676333


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-02-10 @ 7:11 PM
Study NCT ID: NCT05676333
Status: COMPLETED
Last Update Posted: 2023-02-10
First Post: 2016-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Secukinumab in Active Non-segmental Vitiligo
Sponsor: University Hospital, Ghent
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Vitiligo View
None Secukinumab View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vitiligo View
None Secukinumab View